France legalizes medical cannabis cultivation

The product should meet the specifications set by the French Ministry of Health regarding its characteristics, composition, pharmaceutical form, and indications. Additionally, the product should be manufactured following GMP compliance to guarantee its quality, safety, and intended therapeutic use. For more information check the decree regarding the use of medicinal cannabis: https://www.legifrance.gouv.fr/download/file/LHDycqu7Ry3Uw10uhAOeojSbxW9z9z2s0Fxzj_av_CQ=/JOE_TEXTE

At Owlpharma – Consulting, Lda. we have high-level expertise in regulatory support and quality assurance in the field of medicinal cannabis. If you need our support, feel free to contact us: owlpharma@owlpharma.pt